Eye Drop Timolol Maleate 0 point 5 percent Preservative free commod System,Cyclopentolate HCl 1 per
Indian Army
AMBALA, HARYANAPosted 18 Mar
₹1.3 L
GEMGoods4 Documents
Category: Eye Drop Timolol Maleate 0 point 5 percent Preservative
free commod System , Cyclopentolate HCl 1 percent Opth
soln bottle of 5ml , Gatifloxacin 0 point 3 percent eye drop
bott of 5ml , Homatropine Hydrochloride 2 percent Eye
drops , Ketotifen Fumarate 0 point 005 percent Eye drops
5ml , Ketorolac Tromethamine 0 point 4 percent Eye drops
5ml , Brimonidine Tartrate 0 point 2 percent Eye drops 5ml ,
Lotepredenol etabonate 0 point 5 percent bott of 5ml ,
Carboxy Methyl Cellulose 0 point 5 percent eye drop bott of
10ml , Carboxy Methyl Cellulose CMC 1 percent Gel ,
Pilocarpine Nitrate eye solution 2 percent bott of 5ml ,
Povidone 5 percnet eye drop bott of 5ml , Sodium
Chromoglycate eye drops 2 percent bott of 5ml , Sodium
Chloride 6 precent w w ointment Tube of 3gm , Timolol
Maleate eye drop 0 point 5 percent bott of 5ml ,
Tropicamide 1 percent with 5 percent Phenylephrine eye
drop bott of 5ml , Tropicamide Eye solution 1 percent bott of
5ml , Trypan Blue 0 point 6 percent in vial of 1ml Inj ,
Bimatoprost 0 point 03 percent bott of 3ml , Brimonidine
Tartarate 0 point 15 percent w v Polyquad Eye drop 5ml ,
Dorzolamide 2 percent w v plus Timolol 0 point 5 percent w
v Eye drop 5ml , Flurometholone 0 point 1 percent w v Eye
drop 5ml , Hydroxypropyl methyl cellulose 0 point 3 percent
w v Eye drop 10ml , Hyaluronate 0 point 005 percent w v
Eye drop 5ml , Latanoprost 0 point 005 percent w v Eye
drop 5ml , Olopatadine 0 point 2 percent w v Eye drop 5ml ,
Olopatadine 0 point 1 percent with Ketorolac 0 point 4
percent w v Eye drop 5ml , Polyvinyl Alcohol 1 point 4
percent w v Povidone iodine 0 point 6 percent w v Eye drop
10ml , Alcaftadine 0 point 25 percent 05ml , Brinzolamide 1
percent plus Brimonidine 0 point 2 percent w v with
carbomer 970 P and Mannitol with drop tainer Eye drop
USFDA approved 5ml , Hydroxypropyl Methyl Cellulose
Ophthalmic Gel 0 point 3 percent
Deadline
2 Apr 2026